Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orion Breweries is a leading Japanese beverage company and the fifth-largest brewery in Japan, primarily known for its dominant market share of over 60% in the Okinawa Prefecture. Founded in 1957, the company produces a variety of beers, including its flagship 'Orion Draft,' as well as chuhai (spirit-based soda) and soft drinks. In 2019, it was acquired by a consortium led by Nomura Holdings and The Carlyle Group, which focused on expanding its international presence and diversifying its product line. The company successfully completed an initial public offering on the Tokyo Stock Exchange in September 2025. While it maintains a strong focus on regional identity and tourism-related businesses in Okinawa, it has also expanded into the health-conscious beverage market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orion Breweries.